Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | 0.00% | +23.08% | +111.76% |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.54M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -26M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.84
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.85% |
Latest transcript on Imunon, Inc.
1 day | +10.77% | ||
1 week | +28.00% | ||
Current month | -12.20% | ||
1 month | +60.02% | ||
3 months | +157.14% | ||
6 months | +45.06% | ||
Current year | +111.76% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | Dec. 10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-10-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.44 | 0.00% | 44 043 |
24-04-25 | 1.44 | +10.77% | 69,402 |
24-04-24 | 1.3 | -2.26% | 32,477 |
24-04-23 | 1.33 | +4.72% | 51,141 |
24-04-22 | 1.27 | +8.55% | 66,052 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.76% | 13.54M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.55% | 22.02B | |
-17.84% | 20.9B | |
-9.03% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- IMNN Stock